Chad J. Kolean
2022
In 2022, Chad J. Kolean earned a total compensation of $461.6K as Chief Financial Officer at Cellectar Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $113,146 |
|---|---|
| Option Awards | $58,080 |
| Salary | $290,417 |
| Total | $461,643 |
Kolean received $290.4K in salary, accounting for 63% of the total pay in 2022.
Kolean also received $113.1K in non-equity incentive plan and $58.1K in option awards.
Rankings
In 2022, Chad J. Kolean's compensation ranked 4,455th out of 5,690 executives tracked by ExecPay. In other words, Kolean earned more than 21.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,455 out of 5,690 | 22nd |
Division Manufacturing | 2,504 out of 3,095 | 19th |
Major group Chemicals And Allied Products | 1,202 out of 1,406 | 15th |
Industry group Drugs | 1,129 out of 1,307 | 14th |
Industry Pharmaceutical Preparations | 819 out of 949 | 14th |
Source: SEC filing on April 26, 2024.
Kolean's colleagues
We found two more compensation records of executives who worked with Chad J. Kolean at Cellectar Biosciences in 2022.